Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
British Journal of Haematology
|
December 5, 2022
Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo-controlled, double-blind, parallel-group study
Masataka Kuwana, Tomoki Ito, Shugo Kowata, et al.
Cancer Letters
|
August 18, 2004
Disease-related potential of mutations in transcriptional cofactors CREB-binding protein and p300 in leukemias
Kazuyuki Shigeno, Hitoshi Yoshida, Ling Pan, et al.
British Journal of Haematology
|
June 13, 2002
Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma
Naohi Sahara, Akihiro Takeshita, Kazuyuki Shigeno, et al.
Cancer Genetics and Cytogenetics
|
June 15, 2004
Deletion 6p23 and add(11)(p15) leading to NUP98 translocation in a case of therapy-related atypical chronic myelocytic leukemia transforming to acute myelocytic leukemia
Akihiro Takeshita, Kensuke Naito, Kaori Shinjo, et al.
International Journal of Hematology
|
June 4, 2021
Prognostic impact of the dosage of methotrexate combined with tacrolimus for graft-versus-host disease prophylaxis after cord blood transplantation
Miwa Adachi, Daisuke Yokota, Hiroya Hirata, et al.
Experimental Hematology
|
May 27, 2006
Role for interleukin-6 and insulin-like growth factor-I via PI3-K/Akt pathway in the proliferation of CD56- and CD56+ multiple myeloma cells
Naohi Sahara, Akihiro Takeshita, Takaaki Ono, et al.
European Journal of Haematology
|
July 11, 2006
Clinicopathological and prognostic characteristics of CD33-positive multiple myeloma
Naohi Sahara, Kazunori Ohnishi, Takaaki Ono, et al.
Leukemia & Lymphoma
|
August 5, 2004
Phenylarsine oxide (PAO) more intensely induces apoptosis in acute promyelocytic leukemia and As2O3-resistant APL cell lines than As2O3 by activating the mitochondrial pathway
Naohi Sahara, Akihiro Takeshita, Miki Kobayashi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 20, 2019
Universal relation with regime transition for sediment transport in fine-grained rivers
Hongbo Ma, Jeffrey A Nittrouer, Baosheng Wu, et al.
Cancer Chemotherapy and Pharmacology
|
August 29, 2006
Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide
Shinya Fujisawa, Ryuzo Ohno, Kazuyuki Shigeno, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
British Journal of Haematology
|
December 5, 2022
Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo-controlled, double-blind, parallel-group study
Masataka Kuwana, Tomoki Ito, Shugo Kowata, et al.
Cancer Letters
|
August 18, 2004
Disease-related potential of mutations in transcriptional cofactors CREB-binding protein and p300 in leukemias
Kazuyuki Shigeno, Hitoshi Yoshida, Ling Pan, et al.
British Journal of Haematology
|
June 13, 2002
Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma
Naohi Sahara, Akihiro Takeshita, Kazuyuki Shigeno, et al.
Cancer Genetics and Cytogenetics
|
June 15, 2004
Deletion 6p23 and add(11)(p15) leading to NUP98 translocation in a case of therapy-related atypical chronic myelocytic leukemia transforming to acute myelocytic leukemia
Akihiro Takeshita, Kensuke Naito, Kaori Shinjo, et al.
International Journal of Hematology
|
June 4, 2021
Prognostic impact of the dosage of methotrexate combined with tacrolimus for graft-versus-host disease prophylaxis after cord blood transplantation
Miwa Adachi, Daisuke Yokota, Hiroya Hirata, et al.
Experimental Hematology
|
May 27, 2006
Role for interleukin-6 and insulin-like growth factor-I via PI3-K/Akt pathway in the proliferation of CD56- and CD56+ multiple myeloma cells
Naohi Sahara, Akihiro Takeshita, Takaaki Ono, et al.
European Journal of Haematology
|
July 11, 2006
Clinicopathological and prognostic characteristics of CD33-positive multiple myeloma
Naohi Sahara, Kazunori Ohnishi, Takaaki Ono, et al.
Leukemia & Lymphoma
|
August 5, 2004
Phenylarsine oxide (PAO) more intensely induces apoptosis in acute promyelocytic leukemia and As2O3-resistant APL cell lines than As2O3 by activating the mitochondrial pathway
Naohi Sahara, Akihiro Takeshita, Miki Kobayashi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 20, 2019
Universal relation with regime transition for sediment transport in fine-grained rivers
Hongbo Ma, Jeffrey A Nittrouer, Baosheng Wu, et al.
Cancer Chemotherapy and Pharmacology
|
August 29, 2006
Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide
Shinya Fujisawa, Ryuzo Ohno, Kazuyuki Shigeno, et al.
Page
of 4